WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Historically, conjugation of chemical payloads to mAbs (mainly IgG1 & IgG4) by reducing Cysteine inter-chain disulfide bonds dominated the conjugation strategy in the generation of ADCs. However this traditional mechanism was problematic as it typically resulted in significant amounts of heterogeneous products with a wide DAR distribution. Here we introduce the novel and proprietary WuXiDAR4 technology platform for producing ADCs more efficiently and with higher DAR4 population.
This scientific poster was originally presented during the 2023 World ADC Conference in London
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?